126 related articles for article (PubMed ID: 24619174)
1. Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers.
Shi W; Balazs B; Györffy B; Jiang T; Symmans WF; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2014 Apr; 144(3):561-8. PubMed ID: 24619174
[TBL] [Abstract][Full Text] [Related]
2. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
3. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
4. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
5. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
6. Understanding the functional impact of copy number alterations in breast cancer using a network modeling approach.
Srihari S; Kalimutho M; Lal S; Singla J; Patel D; Simpson PT; Khanna KK; Ragan MA
Mol Biosyst; 2016 Mar; 12(3):963-72. PubMed ID: 26805938
[TBL] [Abstract][Full Text] [Related]
7. Data Mining Approaches for Genomic Biomarker Development: Applications Using Drug Screening Data from the Cancer Genome Project and the Cancer Cell Line Encyclopedia.
Covell DG
PLoS One; 2015; 10(7):e0127433. PubMed ID: 26132924
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
[TBL] [Abstract][Full Text] [Related]
9. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
10. Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer.
Dexter TJ; Sims D; Mitsopoulos C; Mackay A; Grigoriadis A; Ahmad AS; Zvelebil M
BMC Syst Biol; 2010 Sep; 4():127. PubMed ID: 20825665
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.
Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L
Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748
[TBL] [Abstract][Full Text] [Related]
12. Parsimonious Gene Correlation Network Analysis (PGCNA): a tool to define modular gene co-expression for refined molecular stratification in cancer.
Care MA; Westhead DR; Tooze RM
NPJ Syst Biol Appl; 2019; 5():13. PubMed ID: 30993001
[TBL] [Abstract][Full Text] [Related]
13. Latent factor analysis to discover pathway-associated putative segmental aneuploidies in human cancers.
Lucas JE; Kung HN; Chi JT
PLoS Comput Biol; 2010 Sep; 6(9):e1000920. PubMed ID: 20824128
[TBL] [Abstract][Full Text] [Related]
14. A systematic comparison of copy number alterations in four types of female cancer.
Kaveh F; Baumbusch LO; Nebdal D; Børresen-Dale AL; Lingjærde OC; Edvardsen H; Kristensen VN; Solvang HK
BMC Cancer; 2016 Nov; 16(1):913. PubMed ID: 27876019
[TBL] [Abstract][Full Text] [Related]
15. ProcessDriver: A computational pipeline to identify copy number drivers and associated disrupted biological processes in cancer.
Baur B; Bozdag S
Genomics; 2017 Jul; 109(3-4):233-240. PubMed ID: 28438487
[TBL] [Abstract][Full Text] [Related]
16. tmle.npvi: targeted, integrative search of associations between DNA copy number and gene expression, accounting for DNA methylation.
Chambaz A; Neuvial P
Bioinformatics; 2015 Sep; 31(18):3054-6. PubMed ID: 26002884
[TBL] [Abstract][Full Text] [Related]
17. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach.
Zhang D; Chen P; Zheng CH; Xia J
Oncotarget; 2016 Jan; 7(4):4298-309. PubMed ID: 26735889
[TBL] [Abstract][Full Text] [Related]
18. Penalized differential pathway analysis of integrative oncogenomics studies.
van Wieringen WN; van de Wiel MA
Stat Appl Genet Mol Biol; 2014 Apr; 13(2):141-58. PubMed ID: 24552967
[TBL] [Abstract][Full Text] [Related]
19. BIOFILTER AS A FUNCTIONAL ANNOTATION PIPELINE FOR COMMON AND RARE COPY NUMBER BURDEN.
Kim D; Lucas A; Glessner J; Verma SS; Bradford Y; Li R; Frase AT; Hakonarson H; Peissig P; Brilliant M; Ritchie MD
Pac Symp Biocomput; 2016; 21():357-68. PubMed ID: 26776200
[TBL] [Abstract][Full Text] [Related]
20. bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
Jézéquel P; Frénel JS; Campion L; Guérin-Charbonnel C; Gouraud W; Ricolleau G; Campone M
Database (Oxford); 2013; 2013():bas060. PubMed ID: 23325629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
